Parkinson Mark Vincent sold $18K of ENSG

Parkinson Mark Vincent sold 100 shares of ENSIGN GROUP, INC (ENSG) at $179.62 on 2026-10-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Parkinson Mark Vincent
Published Oct 19, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENSG
Neutral
high confidence
Mentioned
$ENSG
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENSGNeutralLow
01

Why it matters

A routine insider sale of modest size typically has limited impact on stock price, but it adds to the ongoing monitoring of insider behavior.

02

Market read

The filing is a standard disclosure with low trading relevance; traders may note it but unlikely to act on it.

03

What to watch

Potential upcoming corporate actions or earnings that may have prompted the pre-arranged sale.

Relevance 2/10Novelty 2/10Timing: post-market filing on Oct 19

Background

SEC Form 4 filings disclose insider transactions, providing transparency on insider buying or selling activity.

Company-level read

Ticker impact

$ENSGNeutralHigh confidence
Context

Director Parkinson Mark Vincent sold 100 shares of Ensign Group for $17,962 under a 10b5-1 plan, reducing his holding to 4,400 shares.

Expected impact

likely minimal pressure as the market may view the sale as routine.

Evidence & confidence

The transaction amount is under $20K and represents a small fraction of total shares outstanding, typical of routine 10b5-1 sales.

Market effects

None

None

None

Counterpoint

The sale could be interpreted as a lack of confidence, but the size is too small to signal material concern.

Key entities

  • Ensign Group, Inc.

    US-listed provider of security and risk management services.

  • Parkinson Mark Vincent

    Director of Ensign Group who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DHCMedAI 8/10

DHC Q3 2026 slides: SHOP segment surges 50% despite earnings miss

Diversified Healthcare Trust (DHC) reported Q3 2026 results with a net loss of $0.21 per share, missing estimates. Shares fell 2.58% to $7.54. The SHOP segment saw a 50.4% NOI increase, while medical office and life science faced challenges. DHC raised same-property NOI guidance but lowered EBITDAre and FFO guidance due to management fees. The company has $260.7M in liquidity and a debt-to-EBITDAre ratio of 8.2x.

$ENSGHighAI 8/10

ENSG Q3 deep dive: organic growth and acquisitions drive occupancy and margin gains

Ensign Group (ENSG) reported Q3 revenue of $1.48 billion, missing estimates by 7.1%, but beat adjusted EBITDA expectations. The company raised full-year revenue guidance to $5.91 billion and GAAP EPS guidance to $7.98. Occupancy and skilled mix gains, along with acquisitions, drove growth. Management highlighted clinical model success and market expansion, including entry into Florida.

$ENSGMed

Truist raises Ensign Group stock price target to $210 on margins

Truist Securities raised its price target on The Ensign Group (NASDAQ:ENSG) to $210 from $207, citing strong Q3 results with revenue of $5.67B and EBITDA of $621.52M. The company beat EPS estimates and raised fiscal 2026 guidance. Truist noted positive occupancy trends, labor commentary, and M&A activity. ENSG's Q3 revenue missed estimates but earnings exceeded expectations.

$ENSGHighAI 8/10

The Ensign Group Q3 Earnings Call Highlights

Ensign Group (ENSG) reported Q3 earnings, raising its full-year 2026 adjusted earnings guidance to $7.94-$8.02 per share and revenue outlook to $5.89-$5.92 billion. The company added 22 operations, including nine in Florida, and discussed turnaround efforts for acquired facilities. Ensign had $337.6 million in cash and $512.3 million in cash flow from operations as of Sept. 30, with $1 billion in available capital.

$ENSGHighAI 8/10

Ensign Group Inc (ENSG) Q3 2026 Earnings Call Highlights: Raised Guidance, Strong

Ensign Group Inc (ENSG) raised its 2026 guidance, citing strong occupancy and skilled mix growth. Challenges include integrating 22 new operations, particularly in Florida and Texas, which may take over a year to contribute positively. The company faces risks from reimbursement variations and litigation environments. CEO Barry Port noted strong clinical outcomes and managed care partnerships. CFO Suzanne Snapper highlighted $1B in available funds for growth.

$ENSGMedAI 8/10

Nursing Home Giant Ensign Touts $1B for Future Investments, Census Momentum and New CMS Survey Performance in 3Q

Ensign Group (ENSG) reported Q3 earnings of $2.03 per share, up 23.8% YoY, and revenue of $1.48B, up 14.5%. CEO Barry Port highlighted strong occupancy, skilled-mix growth, and improved CMS survey performance. The company raised full-year 2026 guidance and announced 22 new acquisitions. Ensign has $1B in cash and credit capacity for future investments.